Pharmacology

Action Mechanism of Action Reference
INHIBITOR TNF-alpha inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Arthritis, Juvenile 4 D001171 ClinicalTrials
Hidradenitis Suppurativa 4 D017497 ClinicalTrials
Psoriasis 4 D011565 ClinicalTrials
Inflammatory Bowel Diseases 3 D015212 ClinicalTrials
Cystitis, Interstitial 3 D018856 ClinicalTrials
Giant Cell Arteritis 3 D013700 ClinicalTrials
Pyoderma 3 D011711 ClinicalTrials
Osteoarthritis 3 D010003 ClinicalTrials
Spondylarthropathies 3 D025242 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Behcet Syndrome 3 D001528 ClinicalTrials
Choroidal Neovascularization 2 D020256 ClinicalTrials
Glomerulosclerosis, Focal Segmental 2 D005923 ClinicalTrials
Colitis 2 D003092 ClinicalTrials
Dupuytren Contracture 2 D004387 ClinicalTrials
Sciatica 2 D012585 ClinicalTrials
Inflammation 2 D007249 ClinicalTrials
Osteoarthritis, Knee 2 D020370 ClinicalTrials
Bursitis 2 D002062 ClinicalTrials
Asthma 2 D001249 ClinicalTrials
Netherton Syndrome 2 D056770 ClinicalTrials
Sarcoidosis 2 D012507 ClinicalTrials
Prostatic Hyperplasia 2 D011470 ClinicalTrials
Macular Degeneration 2 D008268 ClinicalTrials
Mucopolysaccharidosis II 1 D016532 ClinicalTrials
Mucopolysaccharidosis VI 1 D009087 ClinicalTrials
Thyroid Neoplasms 1 D013964 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL1201580
FDA SRS FYS6T7F842